BOLIN DAVID ROBERT has a total of 20 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are SHANGHAI TIANCI BIOLOG VALLEY BIOLOG ENGINEERING CO LTD, MADE LABOR SA and COMPASS PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Peptides | |
#5 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Bolin David Robert | 20 |
#2 | Qian Yimin | 16 |
#3 | Hamilton Matthew Michael | 11 |
#4 | Cheung Adrian Wai-Hing | 10 |
#5 | Mcdermott Lee Apostle | 9 |
#6 | Yun Weiya | 9 |
#7 | Firooznia Fariborz | 8 |
#8 | Tan Jenny | 4 |
#9 | Li Shiming | 4 |
#10 | Hayden Stuart | 4 |
Publication | Filing date | Title |
---|---|---|
US2011136792A1 | Novel carboxylic acid analogs as glycogen synthase activators | |
US7939569B1 | Aniline analogs as glycogen synthase activators | |
US2011112158A1 | Benzisoxazole analogs as glycogen synthase activators | |
US2011112147A1 | Indazolone analogs as glycogen synthase activators | |
US2010190979A1 | Diacylglycerol acyltransferase inhibitors | |
US2010113782A1 | Diacylglycerol acyltransferase inhibitors | |
US2010035864A1 | Diacylglycerol acyltransferase inhibitors | |
US2009076275A1 | Diacylglycerol acyltransferase inhibitors | |
US2009170864A1 | Diacylglycerol acyltransferase inhibitors | |
US2009099201A1 | Diacylglycerol Acyltransferase Inhibitors | |
US2009093497A1 | Diacylglycerol acyltransferase inhibitors | |
US2009105273A1 | Diacylglycerol acyltransferase inhibitors |